SCHEMBL19441963

SCHEMBL19441963

C=CC(O)Nc1cccc(N(C(=O)NCCc2ccccc2)c2cc(Nc3ccc(N4CCN(C)CC4)cc3OC)ncn2)c1

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
BTK Q06187 3/20 0.57
JAK3 P52333 9/20 0.44
FGFR1 P11362 1/20 0.44
CTSC P53634 3/20 0.44
CYP3A4 P08684 1/20 0.43
CYP2C9 P11712 1/20 0.43
FGFR3 P22607 1/20 0.43
CYP2C19 P33261 1/20 0.43
SIK1 P57059 1/20 0.42
MELK Q14680 1/20 0.42
SIK2 Q9H0K1 1/20 0.42
SIK3 Q9Y2K2 1/20 0.42
EGFR P00533 4/20 0.42
JAK2 O60674 1/20 0.42
JAK1 P23458 1/20 0.42
TTK P33981 1/20 0.42
FLT3 P36888 1/20 0.42
TXK P42681 1/20 0.42
BLK P51451 1/20 0.42
ITK Q08881 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21081534 0.94 BTK (0.65) BTKJAK3FGFR1CTSCCYP3A4
SCHEMBL17857017 0.90 BTK (0.70) BTKJAK3FGFR1CTSCEGFR
SCHEMBL21081536 0.89 BTK (0.57) BTKJAK3FGFR1CTSCCYP3A4
SCHEMBL21081507 0.89 BTK (0.58) BTKJAK3FGFR1CTSCCYP3A4
SCHEMBL19441964 0.88 BTK (0.57) BTKJAK3FGFR1EGFR
SCHEMBL17857020 0.87 BTK (0.53) BTKJAK3FGFR1CYP3A4CYP2C9
SCHEMBL19441912 0.86 BTK (0.53) BTKJAK3FGFR1CTSCCYP3A4
SCHEMBL17837342 0.84 BTK (0.81) BTKJAK3FGFR1CTSCEGFR
SCHEMBL17857022 0.82 BTK (0.65) BTKJAK3CYP3A4CYP2C9FGFR3
SCHEMBL17857021 0.81 BTK (0.66) BTKJAK3CTSCCYP3A4CYP2C9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9783504-B2 Kinase inhibitors for the treatment of disease DANA-FARBER CANCER INSTITUTE, INC. (US) 2017-10-10 US disclosed